Bigul

Medico Intercontinental Ltd - 539938 - Results For The Quarter Ended 30Th June, 2021

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 14, 2021, inter alia, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2021 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. and other matters as per attached pdf.
14-08-2021
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Outcome for Outcome Of Board Meeting And Compliances Of Regulation 30 And 33 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation, 2015

Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., August 14, 2021, inter alia, considered and approved the following matters: 1. Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended on June 30, 2021 along with Limited Review Report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. and other matters as per Attached file.
14-08-2021
Bigul

Medico Intercontinental Ltd - 539938 - Board Meeting Intimation for Intimation Of Board Meeting In Compliance Of Regulation 29, 30 And 33 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

Medico Intercontinental Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve With reference to the captioned subject, we wish to inform you that the meeting of the Board of Directors of the Company is scheduled to be held on Saturday, 14th August, 2021 at the registered office of the Company situated at 1-5th Floor, Aditraj Arcade, Nr Karma Shreshtha Tower, 100 Ft Rd, Satellite, Ahmedabad, Gujarat - 380015, to inter alia consider, approve and take on record the unaudited Financial Results (Standalone and Consolidated) for quarter ended 30th June, 2021 and any other business items as per agenda circulated. You are requested to kindly take the same on your record.
06-08-2021
Bigul

Medico Intercontinental Ltd - 539938 - Shareholding for the Period Ended June 30, 2021

Medico Intercontinental Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
14-07-2021
Bigul

Medico Intercontinental Ltd - 539938 - Statement Of Investor Complaints For The Quarter Ended June 2021

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Puneeta SharmaDesignation :- Company Secretary and Compliance Officer
06-07-2021
Bigul

Medico Intercontinental Ltd - 539938 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir / Ma'am, We are enclosing herewith the Confirmation Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th June, 2021. Kindly take the above on your record.
06-07-2021
Bigul

Medico Intercontinental Ltd - 539938 - Closure of Trading Window

Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and in compliance with circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019 issued by BSE Limited, we wish to inform you that the 'Trading Window' for dealing in the securities of the Company has already been closed and shall remain closed for all the designated persons and their immediate relatives till the conclusion of 48 hours after the declaration of financial results of the company for the quarter ended June 30, 2021. You are requested to disseminate the above information on your website.
30-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Dear Sir / Ma'am, We hereby wish to inform you that the Audited financial results (Standalone & Consolidated) for the quarter and financial year ended 31st March, 2021 were approved at the meeting of Board of Directors held on Tuesday, 29th June, 2021. In continuation to the same, the newspaper clipping duly published in English Newspaper and Gujarati Newspaper is enclosed herewith. This is for your information and records.
30-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Declaration Regarding Regulation 23 (9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 In Respect Of Related Party Disclosures

Dear Sir/Ma'am, As per the provisions of 15(2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('LODR Regulations'), the compliances with corporate governance provisions as specified in Regulations 17 to 27 are applicable to the Company only if it's paid up Capital exceeds Rs. 10 Crores and if Net worth is above Rs. 25 Crores. As on 31st March, 2021, the paid up share capital of the company is Rs. 3,24,90,000/- (Rupees Three Crores Twenty Four Lakhs Ninety Thousand only) which does not exceed Rs. 10 Crores limit and the Net Worth of the Company is Rs. 6,34,00,160/- (Rupees Six Crores Thirty Four Lakhs and One Hundred Sixty only) which does not cross Rs. 25 Crores. Hence, the compliance of provisions of Regulations 17 to 27 of SEBI (LODR) Regulations, 2015 is not applicable to the Company. In light of the above, the Company do not fall under the ambit of Regulation 23 (9) of SEBI (LODR) Regulations, 2015. Kindly take the same on record.
29-06-2021
Bigul

Medico Intercontinental Ltd - 539938 - Financial Results For Quarter And Financial Year Ended 31St March, 2021

Dear Sir/Ma'am, Pursuant to provisions of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today i.e., June 29, 2021, inter alia, considered and approved: 1. Audited Standalone and Consolidated Financial Results of the Company for the quarter and Financial year ended on March 31, 2021 along with Auditors report issued by M/s. V Goswami & Co, Statutory Auditors of the Company. 2. Re-Appointment of M/s. Yash Mehta & Associates, Practicing Company Secretary, Ahmedabad as Secretarial Auditor of the Company for the F.Y. 2021-22. 3. Re-Appointment of M/s. MJV & Co, Chartered Accountants, Ahmedabad as an Internal Auditor of the Company for the F.Y. 2021-22. The Board Meeting of the Company commenced at 12:30 PM and concluded at 02:20 PM. This is for your information and records.
29-06-2021
Next Page
Close

Let's Open Free Demat Account